两家公司表示,在合作的初始阶段,Ares开发了一个数字抗感染平台,将微生物学实验室实践与先进的生物信息学和人工智能方法相结合,以帮助识别有效的抗菌化合物...查看全文
蹊之美股生物医药2021-10-08 00:15
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Voyager Therapeutics (NASDAQ:VYGR) +56%
Acer Therapeutics (NASDAQ:ACER) +16%
Molecular Partners (NASDAQ:MOLN) +10%
Rafael (NYSE:RFL) +6%
Arcturus Therapeutics (NASDA...查看全文
东哥_Singapore2021-03-08 23:42
$Jaguar Health(JAGX)$ 给力点啊,速度冲2.5!刚才在2.9的OPGN跟1.85的你之间,最后选的你!不要让我失望啊!OPGN已经爆拉了!!!$OpGen(OPGN)$查看全文
$OpGen(OPGN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001079973-22-000501 Act: 34 Size: 216 KB 网页链接
$OpGen(OPGN)$ DEF 14A Other definitive proxy statements Accession Number: 0001079973-22-000495 Act: 34 Size: 401 KB 网页链接
$OpGen(OPGN)$ PRE 14A Other preliminary proxy statements Accession Number: 0001079973-22-000429 Act: 34 Size: 402 KB 网页链接
$OpGen(OPGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001079973-22-000394 Size: 5 KB 网页链接
$OpGen(OPGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001079973-22-000392 Size: 5 KB 网页链接
$OpGen(OPGN)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001079973-22-000358 Act: 34 Size: 10 MB 网页链接
$OpGen(OPGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001079973-22-000352 Act: 34 Size: 306 KB 网页链接
$OpGen(OPGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001079973-22-000214 Size: 12 KB 网页链接
$OpGen(OPGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001079973-22-000215 Size: 12 KB 网页链接
$OpGen(OPGN)$ 8-K Current report, item 3.01 Accession Number: 0001079973-22-000204 Act: 34 Size: 195 KB 网页链接